Inovio Pharmaceuticals Inc. (INO) Social Stream
INOVIO PHARMACEUTICALS INC (INO) Price Targets From Analysts
Use the tables below to see what analysts covering INOVIO PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 9 | $35 | $6 | $13.111 | $0.86 | 1424.53% |
| 2021-11-12 | 9 | $35 | $6 | $13 | $0.86 | 1411.63% |
| 2021-12-14 | 8 | $35 | $6 | $13.875 | $0.86 | 1513.37% |
| 2021-12-29 | 8 | $35 | $6 | $13.625 | $0.86 | 1484.3% |
| 2022-02-09 | 8 | $35 | $6 | $13.375 | $0.86 | 1455.23% |
| 2022-03-04 | 8 | $30 | $3 | $11 | $0.86 | 1179.07% |
| 2022-04-08 | 8 | $30 | $3 | $9.714 | $0.86 | 1029.53% |
| 2022-05-11 | 8 | $11 | $1 | $5.333 | $0.86 | 520.12% |
| 2022-05-16 | 8 | $11 | $1 | $5.166 | $0.86 | 500.7% |
| 2022-07-19 | 7 | $11 | $2 | $5.6 | $0.86 | 551.16% |
| 2022-08-13 | 6 | $11 | $2 | $5.4 | $0.86 | 527.91% |
| 2022-08-17 | 7 | $11 | $2 | $5.4 | $0.86 | 527.91% |
| 2022-09-17 | 7 | $8 | $2 | $4.2 | $0.86 | 388.37% |
| 2022-10-31 | 7 | $5 | $2 | $3 | $0.86 | 248.84% |
| 2022-11-13 | 7 | $5 | $2 | $2.8 | $0.86 | 225.58% |
| 2023-02-08 | 6 | $3 | $2 | $2.333 | $0.86 | 171.28% |
| 2023-03-02 | 6 | $2 | $1.2 | $1.733 | $0.86 | 101.51% |
| 2023-03-03 | 6 | $2 | $1 | $1.4 | $0.86 | 62.79% |
| 2023-07-31 | 6 | $2 | $1 | $1.333 | $0.86 | 55% |
| 2023-08-09 | 6 | $2 | $0.3 | $1.1 | $0.86 | 27.91% |
| 2023-08-10 | 5 | $2 | $0.3 | $0.933 | $0.86 | 8.49% |
| 2023-11-10 | 5 | $2 | $0.3 | $0.9 | $0.86 | 4.65% |
The Trend in the Analyst Price Target
INO's average price target has moved down $4.4 over the prior 16 months.
Over the past 41 weeks, INO's average upside potential has been 122.86%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-26 | 6 | 3 | 2.0 | 2.333 | 1.660 | 40.54% |
| 2023-03-02 | 6 | 2 | 1.2 | 1.733 | 1.300 | 33.31% |
| 2023-06-06 | 6 | 2 | 1.0 | 1.333 | 0.564 | 136.35% |
| 2023-07-31 | 6 | 2 | 1.0 | 1.333 | 0.532 | 150.56% |
| 2023-11-10 | 4 | 2 | 0.3 | 0.900 | 0.349 | 157.88% |
INO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3.2 | 0 | 0 | 4 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
INO's average broker recommendation rating worsened by 0.29 over the prior 16 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for INO as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, INOVIO PHARMACEUTICALS INC's average analyst price target is higher than 163.24% of them.
- In the context of Medical Equipment stocks, INOVIO PHARMACEUTICALS INC's variance in analysts' estimates is lower than -2404.53% of them.
- In terms of how INOVIO PHARMACEUTICALS INC fares relative to stocks in the mid market cap category, note that its upside potential (average analyst target price relative to current price) is higher than 2232.65% of that group.
- INOVIO PHARMACEUTICALS INC's number of analysts covering the stock is greater than 1124.6% of stocks in the mid market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Medical Equipment industry with the ratings most similar to INOVIO PHARMACEUTICALS INC are LUNG, NNOX, and ICUI.
View All Top Stocks by Price Target
What is the outlook for INO? Use POWR Ratings for clearer insight into price direction.